InjectionClinical Overview
Betamethasone (Injection IP 4mg/ml) is a potent, long-acting synthetic glucocorticoid on the WHO Model List of Essential Medicines. Structurally the 16-beta isomer of dexamethasone, it provides potent anti-inflammatory action with zero mineralocorticoid effect and readily crosses the placenta to stimulate fetal type II pneumocyte maturation and surfactant production. Indicated for antenatal prophylaxis of neonatal respiratory distress syndrome (RDS) and intraventricular hemorrhage in preterm labor, severe rheumatoid arthritis, angioedema, and dermatological autoimmune flares.
Active Pharmaceutical Ingredients
Verified Clinical References
Usage Guidelines
For Deep Intramuscular (IM) injection ONLY: For antenatal fetal lung maturation: 12 mg IM administered as two doses 24 hours apart (course complete at 48 hours). Administer into the gluteal muscle; do NOT administer intravenously.
General Administration Advice: Adhere strictly to the prescribed dosage, frequency, and treatment course. For oral medications, swallow with sufficient water. Never stop antibiotics, psychiatric medications, or antihypertensives abruptly without clinical direction.
Possible Side Effects
Common: Headache, dizziness, insomnia, facial flushing, increased appetite, and mild gastric irritation. Rare/Severe: Severe immunosuppression, adrenal suppression, hypokalemia, steroid-induced hyperglycemia, and glaucoma.
*Note: Individual physiological responses vary. While many patients experience few or no side effects, notify your treating physician if adverse reactions persist or if hypersensitivity (angioedema, skin rash, dyspnea) occurs.
Precautions & Warnings
Contraindicated in untreated systemic infections and live viral immunization. In maternal preterm administration, monitor maternal blood glucose (steroid hyperglycemia) and rule out chorioamnionitis before administration.
Schedule H (Prescription Required)
This medication is scheduled under statutory drug regulatory frameworks (CDSCO / Drugs & Cosmetics Rules). Dispensing requires a valid medical prescription from a registered medical practitioner. Self-medication or unsupervised dosage adjustment carries significant clinical risks.
Medical Disclaimer: Statutory Gynecological, Obstetric & Endocrinological Disclaimer: The information provided is for educational and price-transparency purposes only and does not constitute medical advice or reproductive healthcare guidance. Hormonal medications, uterotonics, corticosteroids, fertility therapies, and emergency contraceptives have profound systemic actions and must be administered strictly under the supervision of a registered gynecologist, obstetrician, or endocrinologist.
Betamethasone Valerate 0.1% and Neomycin Sulfate 0.5% Cream
Betamethasone Valerate / Dipropionate is a potent topical corticosteroid on the WHO Model List of Essential Medicines. It suppresses cutaneous inflammatory edema, erythema, and pruritus in eczema, psoriasis, and severe contact dermatitis. Often formulated in combination with Fusidic Acid, Gentamicin, or Miconazole to treat secondarily infected dermatoses.
Betamethasone Valerate 0.12% and Clioquinol 3% Cream
Betamethasone Valerate / Dipropionate is a potent topical corticosteroid on the WHO Model List of Essential Medicines. It suppresses cutaneous inflammatory edema, erythema, and pruritus in eczema, psoriasis, and severe contact dermatitis. Often formulated in combination with Fusidic Acid, Gentamicin, or Miconazole to treat secondarily infected dermatoses.
Betamethasone Sodium Phosphate Tablets 0.5 mg
Betamethasone (Sodium Phosphate Tablets IP 0.5mg) is a potent, long-acting synthetic glucocorticoid on the WHO Model List of Essential Medicines. Structurally the 16-beta isomer of dexamethasone, it provides potent anti-inflammatory action with zero mineralocorticoid effect and readily crosses the placenta to stimulate fetal type II pneumocyte maturation and surfactant production. Indicated for antenatal prophylaxis of neonatal respiratory distress syndrome (RDS) and intraventricular hemorrhage in preterm labor, severe rheumatoid arthritis, angioedema, and dermatological autoimmune flares.
Betamethasone Dipropionate 0.05% and Salicylic Acid 3% Ointment
Betamethasone Valerate / Dipropionate is a potent topical corticosteroid on the WHO Model List of Essential Medicines. It suppresses cutaneous inflammatory edema, erythema, and pruritus in eczema, psoriasis, and severe contact dermatitis. Often formulated in combination with Fusidic Acid, Gentamicin, or Miconazole to treat secondarily infected dermatoses.